Stockholm Life gathers
life science in Stockholm

You are here

Medicinal product is more than molecule: Impact of formulation development on drug delivery and manufacturing

Wednesday, 22 March, 2017 - 08:00

Development of formulation is one of the steps in the progress of development of medicinal product from lab bench to bedside. This breakfast seminar will focus on two parameters important for developing a formulation: how a product will be administered to a patient and how it is envisioned to be manufactured. 

What is a medicinal product? In many minds, its essence comes to the active component, the molecule itself. Yet there are a variety of other aspects that define a medicinal product where the formulation is one key aspect. In combination they all lead to wheather a drug will be accepted by patients, caregivers, health systems and health providers. 

A formulation can be defined as a suitable composition of active compotent, i.e. drug substance, together with other components, i.e. excipients. The composition is aimed to achieve a drug product that is suitable for its purpose. 

Development of the formulation is one of the steps in the progress of development of medicinal product from lab bench to bedside. The formulation itself influences and is influenced by a large number of different parameters. 

During the seminar focus will be on two parameters important for develping a formulation:
1) how a product will be administered to a patient 
2) how it is envisioned to be manufactured

APL would like to invite you to a seminar, where we will give some theoretical background on formulation development as well as several case studies. Case studies come from both past and ongoing work at APL. 

Speakers:

  • Christina Gustafsson: Formulation Scientist at APL, has a M.Sc. Pharm and PhD in Pharmaceutics from Uppsala University and long experience from pharmaceutical industry/development and the Swedish Medical Product Agency. 
  • Bengt Hedin: Certified Pharmacist and Chemical Engineer, with vast experience in dosage forms such as hard gelatine capsules, parenterals, suppositories, tablets, creams, pastes, suspensions, gels and oral dissolvable films. Recently selected as a member of European Directorate for the Quality of Medicines (EDQM) in the expert group Paediatric Formulary. 


When: March 22, 08.00-09.00 (breakfast is served from 07.30)  
Where: Wenner-Gren Center, 24th floor (take the elevator to floor 23), Sveavägen 166, Stockholm

There is a limited number of seats, please register before March 15th. If you need to cancel, please contact klara.gustafsson@ssci.se or use the link you recieved in the confimation e-mail. 
Registration is now closed. 

Please note that the seminar will be in English.